MyPal adopts a patient-centred approach harnessing technology for the benefit of patients, tailored to their specific and evolving needs, while also taking into account the fundamentally different profiles of patients and caregivers of different age groups, as well as differences in digital and health literacy.
This approach holds the potential of overcoming the limitations of existing PRO systems, thus, actively engaging patients and their caregivers towards a more effective delivery of supportive care for improving QoL, advancing care planning, patient and caregiver satisfaction and lowering healthcare utilisation without a negative impact on survival.
In order to demonstrate the effectiveness of the proposed intervention, MyPal will conduct clinical studies across diverse populations of cancer patients and in different healthcare contexts. As for cost-effectiveness, a cost-utility analysis will be applied based on the comparative measurements (and change over time) of health-related QoL (as well as costs). Cost calculations will be based on the third-party payer perspective.
The implementation of the MyPal intervention includes 4 phases, namely:
Phase A: Intervention Design (MyPal Study Protocols and User Requirements)
Phase B: Technical Implementation-Adaptation of MyPal PRO Components and Tools
Phase C: Clinical Studies of the MyPal Intervention
Phase D: Impact Assessment of the MyPal Intervention
The timing and the links among these phases are depicted in the following figure.